Simplex Trading’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-400
| Closed | -$1K | – | 9571 |
|
|
2025
Q2 | $1K | Hold |
400
| – | – | ﹤0.01% | 8347 |
|
|
2025
Q1 | $1K | Sell |
400
-200
| -33% | -$1.21K | ﹤0.01% | 8236 |
|
|
2024
Q4 | $4K | Buy |
+600
| New | +$4.47K | ﹤0.01% | 7754 |
|
|
2024
Q1 | – | Sell |
-600
| Closed | -$5K | – | 9377 |
|
|
2023
Q4 | $5K | Sell |
600
-1,580
| -72% | -$13.9K | ﹤0.01% | 7867 |
|
|
2023
Q3 | $25K | Buy |
2,180
+1,270
| +140% | +$22.5K | ﹤0.01% | 6426 |
|
|
2023
Q2 | $22K | Sell |
910
-210
| -19% | -$5.47K | ﹤0.01% | 6674 |
|
|
2023
Q1 | $35K | Buy |
1,120
+820
| +273% | +$47.4K | ﹤0.01% | 6328 |
|
|
2022
Q4 | $21K | Sell |
300
-7,690
| -96% | -$570K | ﹤0.01% | 6829 |
|
|
2022
Q3 | $687K | Sell |
7,990
-3,040
| -28% | -$295K | ﹤0.01% | 3097 |
|
|
2022
Q2 | $912K | Buy |
11,030
+740
| +7% | +$65.3K | ﹤0.01% | 2726 |
|
|
2022
Q1 | $1.71M | Buy |
10,290
+8,630
| +520% | +$1.24M | ﹤0.01% | 2271 |
|
|
2021
Q4 | $277K | Buy |
1,660
+1,460
| +730% | +$165K | ﹤0.01% | 4688 |
|
|
2021
Q3 | $10K | Hold |
200
| – | – | ﹤0.01% | 8920 |
|
|
2021
Q2 | $10K | Buy |
200
+198
| +9,900% | +$11.2K | ﹤0.01% | 9091 |
|
|
2021
Q1 | $11K | Buy |
+2
| New | +$117 | ﹤0.01% | 7842 |
|
|
2020
Q3 | – | Sell |
-3
| Closed | -$15K | – | 8137 |
|
|
2020
Q2 | $15K | Buy |
+3
| New | +$151 | ﹤0.01% | 6414 |
|
Simplex Trading's KZR Position: Q3 2025 in Review
Simplex Trading sold out of Kezar Life Sciences (KZR) in Q3 2025, closing a stake of 43 shares.
Simplex Trading first reported a position in KZR in Q2 2020 and held it in 17 quarters. The position peaked at $259K in Q4 2021. 39 funds tracked by Wall St. Rank hold KZR as of Q3 2025.
- Simplex Trading reported no remaining Kezar Life Sciences position as of Q3 2025 after selling out during the quarter.
- Simplex Trading sold 43 Kezar Life Sciences shares in Q3 2025.
- Simplex Trading first reported a position in Kezar Life Sciences in Q2 2020 and held it in 17 quarters.
- Simplex Trading's Kezar Life Sciences position peaked at $259K in Q4 2021.
- 39 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q3 2025.
Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.